Alnylam’s Maraganore to lead BIO

BIO is expected to announce that John Maraganore will be its next chairman. Maraganore is CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY).

BIO had been slated to elect Paul Hastings chairman. He is chairman and CEO of OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), as well as BIO's current vice chairman. Hastings has decided to step aside in order to devote his full attention to OncoMed, three individuals involved in the decision told BioCentury...